Gemer Sita 50mg/2mg/1000mg Tablet IR
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Sitagliptin (50mg) + Glimepiride (2mg) + Metformin (1000mg)
Overview Gemer Sita 50mg/2mg/1000mg Tablet IR
Tri-Med Glycemic 50/2/1000mg tablets are a triple-drug formulation for managing elevated blood sugar in individuals with type 2 diabetes. This medication is typically prescribed when dietary changes, exercise, and other therapies prove insufficient to achieve satisfactory blood glucose control. For optimal results, consume Tri-Med Glycemic with food, consistently at the same time daily. Dosage and treatment duration are personalized, based on your individual response and health status. Regular blood sugar monitoring is often recommended while taking this combination therapy. Continuous use is crucial, even with seemingly controlled blood sugar, as abrupt cessation may lead to dangerous spikes and potential complications. This medicine forms part of a comprehensive diabetes management plan, encompassing healthy eating, regular physical activity, and weight management, as lifestyle factors significantly influence diabetes control. Common side effects include low blood sugar and headache; other potential side effects include nausea, diarrhea, stomach pain, constipation, and vomiting. Report persistent or worsening side effects to your physician, who can adjust the dosage or explore alternative treatments. This medication is contraindicated for individuals with type 1 diabetes, acute or chronic metabolic acidosis (including diabetic ketoacidosis), active bladder cancer, or a history of bladder cancer. Always disclose all other medications to your doctor, as interactions are possible. Consult your physician before using Tri-Med Glycemic if you are pregnant or breastfeeding.
Primary Ingredients of Gemer Sita 50mg/2mg/1000mg Tablet IR
No text provided. Please provide the text you would like me to rephrase.
Uses of Gemer Sita 50mg/2mg/1000mg Tablet IR
Managing type 2 diabetes
Major Benefits of Gemer Sita 50mg/2mg/1000mg Tablet IR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Consume Gemer Sita 50mg/2mg/1000mg Immediate-Release tablets with food.
Common Side effects of Gemer Sita 50mg/2mg/1000mg Tablet IR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Abdominal pain
- Constipation
- Vomiting
How to use Gemer Sita 50mg/2mg/1000mg Tablet IR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. The Gemer Sita 50mg/2mg/1000mg Immediate-Release tablet should be administered with a meal.
How Gemer Sita 50mg/2mg/1000mg Tablet IR works:
Gemer Sita tablets (50mg/2mg/1000mg Immediate Release) combine three antidiabetic agents to manage blood glucose. Sitagliptin boosts incretin levels, prompting the pancreas to release more insulin and inhibiting hepatic glucose production when blood sugar is elevated. Glimepiride stimulates insulin secretion from the pancreas, improving the body's insulin utilization. Metformin reduces glucose absorption from ingested food and liver glucose production, while enhancing insulin sensitivity to regulate blood glucose.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol ingestion and Gemer Sita 50mg/2mg/1000mg Tablet IR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Gemer Sita 50mg/2mg/1000mg Tablet IR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Gemer Sita 50mg/2mg/1000mg Tablet IR are likely incompatible. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
The use of Gemer Sita 50mg/2mg/1000mg immediate-release tablets requires careful consideration in individuals with advanced kidney impairment. Dosage modification of Gemer Sita 50mg/2mg/1000mg immediate-release tablets might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Gemer Sita 50mg/2mg/1000mg immediate-release tablets. Dosage modification of Gemer Sita 50mg/2mg/1000mg immediate-release tablets may be necessary. Physician consultation is recommended.
What if you forget to take Gemer Sita 50mg/2mg/1000mg Tablet IR :
Should you forget a Gemer Sita 50mg/2mg/1000mg Tablet IR dose, take it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Gemer Sita 50mg/2mg/1000mg Tablet IR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |


